Last thirtieth
of November, NKCL Bio Group Inc. won the ninth 2021 Future Creative Superiority
Company Grand Award in the Innovative Immune Cell Cultivation Technology Field
for the second time in a row.
‘Future
Creative Superiority Company Grand Award’ is an award to discover and select
companies that lead the fields of customer satisfaction excellency, enhance the
job creation etc., supported by Ministry of Employment and Labor and Ministry
of Science and ICT and hosted by mass media Moneytoday.
NKCL was
nominated, under the purpose of selection of Ministry of Science and ICT, with
its growth of higher value-added industry that is based with the knowledge and
technology, not with the increasing industry of simple labor intensive and its
contribution to training and increasing technology, production and service
personnel.
Through the
production facility expansion of GMP certified Automated Cultivation System in
2021, NKCL Bio Group Inc. made approximately over 300% rate of job creation
compare to previous year. And in 2022, NKCL Bio Group is expecting
approximately over 1000% rate of job creation.
Furthermore,
NKCL Bio Group is promoting invigorate local economy and increase local income
and job creation by operating Immune Bakery HACCP certified plant and opening
franchises.
NKCL Bio Group is
a Korean incorporate that researches and develops NK Immune Cell Treatment which
is highlighted as fourth industry, so called the next generation industry. As immunity
became the most important interest, NKCL Bio Group constructs and operates one on
one customized immune cell treatments’ immune care platform through GMP certified
Automated Cultivation based with excellent technology.
Especially, through
experiencing lacking numbers of vaccine, the whole world suffered and realized the
serious decline in productivity of treatment production capacity. At the same time,
through differentiated competitiveness with high-tech cell treatment and GMP certified
Automated Cultivation system, NKCL is expecting increase in productivity and cost
reduction effect on cell treatment.
After its establishment
as a company, NKCL Bio Group is presenting daily life related technologies and products
by expanding medi-food bio field and microbiome technology. NKCL is growing as a
successful immune care brand with the products clothed with brand concept of ‘immune
care,’ and NK Immune Bakery Café.
Starting with the
opening of Dongtan main store, NK Immune Bakery Café is successfully operating by
expanding the number of stores to twenty-three stores in nationwide. Dongtan main
store, presenting dinner menus as main product, is leading by the Main Chef Kim
Yang-SU, who has a splendid history of career at Eden Hotel in Italy; ONL in Cheongdam,
Korea; and as General Chef of La Foresta of Sejong Center for the Performing Arts.
NKCL Bio Group said,
“Not only we actively setup Personalized Immune Care Platform in 2022, but also
by February, 2022, cooperating with hospitals and clinics in Dongtan district, NKCL
is focusing on establishing ‘NK Human Immune Treatment Center,’ the comprehensive
treatment plex mall, including Immune Examination Center, Immune Treatment Center,
Immune Drug Store, Immune Café and etc.
Moreover, NK Immune
Water of NKCL Bio Group Inc. won ‘2021 the Best Brand of Consumers’ Choice,’ along
with LG Dios, Starbucks, Chevrolet, Air Days, San Pellegrino. Also, NKCL Bio Group
Inc. won the Grand Award of the Promising Bio Enterprise Field for the second consecutive
year at the 2021 Korea Future Management Awards hosted by Herald Economy and Korea
Herald.
https://www.sisunnews.co.kr/news/articleView.html?idxno=152745